July 17, 2013
"We can't focus entirely on public health at the expense of individuals," says Joel Gallant, M.D. In this interview with Fred Schaich of the International Foundation for Alternative Research in AIDS (IFARA) at IAS 2013, Gallant discusses what the newly updated World Health Organization HIV treatment guidelines mean for the future of antiretroviral therapy in resource-limited parts of the world. He focuses in particular on the idea that HIV treatment in poorer areas should not merely be about getting people on antiretrovirals, but about ensuring overarching quality of care for patients beyond providing medications.
Gallant also reflects on some of the key takeaway messages from IAS 2013, including new reflections on the extremely long-term effects of HIV infection among patients on treatment and the realities of day-to-day HIV clinical care in the U.S.
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
No comments have been made.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|